Free Newsletter
FDA: Drug combo spawns muscle injury
Muscle injury warning, part two: The FDA says mixing Zocor (simvastatin), with the heart rhythm med amiodarone boosts the risk of muscle injury, especially in elderly patients. The same goes for Vytorin, because it contains simvastatin. Amiodarone is marketed by Wyeth under the brand name Cordarone and as Pacerone by Upsher-Smith Laboratories.
The FDA has warned about the risks of combining a statin and amiodarone before. But since that warning, in 2002, the agency has received 52 reports of serious muscle injury to patients on the combo, and almost all of them had to be hospitalized.
As you know, muscle injury is a danger attendant on all statin meds, especially at higher doses. The overall risk is low, but if it happens, it can be serious, even fatal. And this is the second bit of news in less than a week about a statin interacting dangerously with another med; in Ireland, one man recently died while he was taking Lipitor along with an antibiotic, fucidic acid.
- read the Associated Press story
- check out the Wall Street Journal coverage
Related Articles:
Merck slashes Zocor price as patent expires
Ireland probes Lipitor patient's death
Comments
Statins and macrolide antibiotics as a class should never be taken together.
When was Amiodarone approvoved for use in the U.S.? ( as Cordarone in pill form)
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





